Improving clinical trial design in acute lung injury

Critical Care Medicine

Volumn 31, Issue 4 SUPPL., 2003, Pages

  Wood, Kelly A ^a   Huang, David ^a   Angus, Derek C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; NEW DRUG; PLACEBO;

ACUTE DISEASE; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; HUMAN; HUMAN RIGHTS; INFORMED CONSENT; LUNG INJURY; METHODOLOGY; MORBIDITY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; SAMPLE SIZE; SEPSIS; STANDARD; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0037394909     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000057908.11686.b3     Document Type: Conference Paper

References (51)

1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: The Acute Respiratory Distress Network. N Engl J Med 2000; 342:1301-1308
2. Grasso S, Mascia L, Del Turco M, et al: Effects of recruiting maneuvers in patients with acute respiratory distress syndrome ventilated with protective ventilatory strategy. Anesthesiology 2002; 96:795-802
3. Dellinger RP, Zimmerman JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Resuits of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998; 26:15-23
4. Long W, Thompson T, Sundell H, et al: Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome: The American Exosurf Neonatal Study Group I. J Pediatr 1991; 118:595-605
5. Gregory TJ, Steinberg KP, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315
6. Bernard GR, Luce JM, Sprung CL, et al: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317:1565-1570
7. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354
8. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
9. Knaus WA, Sun X, Nystrom O, et al: Evaluation of definitions for sepsis. Chest 1992; 101:1656-1662
10. Rubenfeld GD, Doyle RL, Matthay MA: Evaluation of definitions of ARDS. Am J Respir Crit Care Med 1995; 151:1270-1271
11. Fuhrman BP, Abraham E, Dellinger RP: Futility of randomized, controlled ARDS trials: A new approach is needed. Crit Care Med 1999; 27:431-433
12. Navarrete-Navarro P, Rodriguez A, Reynolds N, et al: Acute respiratory distress syndrome among trauma patients: Trends in ICU mortality, risk factors, complications and resource utilization. Intensive Care Med 2001; 27:1133-1140
13. Villar J, Slutsky AS: The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140:814-816
14. Rubenfeld GD, Caldwell EC, Martin DM, et al: The incidence of acute lung injury (ALI) in adults in the US: Results of the King County Lung Injury Project. Am J Respir Crit Care Med 2002; 165:A219
15. Marshall RP, Webb S, Hill MR, et al: Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 2002; 121:68S-69S
16. Hatton J, Lu WY, Rhoney DH, et al: A stepwise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit. Surg Neurol 1996; 46:493-499
17. Brun-Buisson C: Preventing nosocomial infections to improve outcome of intensive care. In: Surviving Intensive Care: Update in Intensive Care and Emergency Medicine No. 39. Angus DC, Carlet J (Eds). Berlin, Springer-Verlag, 2003, pp 247-255
18. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
19. Kollef MH, Shapiro SD, Silver P, et al: A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 1997; 25:567-574
20. Wolf MM, Varigos GA, Hunt D, et al: Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2:52-53
21. Kress JP, Pohlman AS, O'Connor MF, et al: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477
22. Guideline for prevention of intravascular device-related infections: Part II. Recommendations for the prevention of nosocomial intravascular device-related infections. Am J Infect Control 1996; 24:277-293
23. Cohen MM, Rose DK, Yee DA: Changing anesthesiologists' practice patterns: Can it be done? Anesthesiology 1996; 85:260-269
24. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
25. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction: The GUSTO Investigators. N Engl J Med 1993; 329;673-682
26. A comparison of reteplase with alteplase for acute myocardial infarction: The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med 1997; 337:1118-1123
27. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction: The Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. N Engl J Med 1997; 337:1124-1130
28. Ware JH, Antman EM: Equivalence trials. N Engl J Med 1997; 337:1159-1161
29. Bernard GR, Wheeler AP, Russell JA, et al: The effects of ibuprofen on the physiology and survival of patients with sepsis: The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336:912-918
30. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
31. Angus DC, Musthafa AA, Clermont G, et al: Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Meal 2001; 163:1389-1394
32. Quartin AA, Schein RM, Kett DH, et al: Magnitude and duration of the effect of sepsis on survival. JAMA 1997; 277:1058-1063
33. Packer M: Effect of oral milrinone on mortality in severe chronic heart-failure. Herz Kreislauf 1992; 24:276
34. Echt DS, Liebson PR, Mitchell LB, et al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-788
35. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
36. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417
37. Garland JS, Alex CP, Pauly TH, et al: A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial. Pediatrics 1999; 104:91-99
38. Taylor HG, Klein N, Hack M: School-age consequences of birth weight less than 750 g: A review and update. Dev Neuropsychol 2000; 17:289-321
39. O'Shea TM, Kothadia JM, Klinepeter KL, et al: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics 1999; 104:15-21
40. Rubenfeld GD, Angus DC, Pinsky MR, et al: Outcomes research in critical care: Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. Am J Respir Crit Care Med 1999; 160:358-367
41. Black NA, Jenkinson C, Hayes JA, et al: Review of outcome measures used in adult critical care. Crit Care Med 2001; 29:2119-2124
42. McHugh LG, Milberg JA, Whitcomb ME, et al: Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:90-94
43. Davidson TA, Caldwell ES, Curtis JR, et al: Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999; 281:354-360
44. Fish SS: Research ethics in emergency medicine. Emerg Med Clin North Am 1999; 17:461-74, xii
45. McRae AD, Weijer C: Lessons from everyday lives: a moral justification for acute care research. Crit Care Med 2002; 30:1146-1151
46. Coppolino M, Ackerson L: Do surrogate decision makers provide accurate consent for intensive care research? Chest 2001; 119:603-612
47. Responsible Research: A Systems Approach to Protecting Research Participants. Washington, DC, Institute of Medicine, 2002
48. Silverman H, Hull SC, Sugarman J: Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med 2001; 29:235-241
49. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002; 166:1510-1514
50. Thompson BT, Hayden D, Matthay MA, et al: Clinicians' approaches to mechanical ventilation in acute lung injury and ARDS. Chest 2001; 120:1622-1627
51. Hickling KG, Walsh J, Henderson S, et al: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-1578